Compare STIM & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STIM | NCSM |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.5M | 97.3M |
| IPO Year | 2018 | 2017 |
| Metric | STIM | NCSM |
|---|---|---|
| Price | $2.09 | $36.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 11.3K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.53 |
| Revenue | $129,873,000.00 | ★ $178,000,000.00 |
| Revenue This Year | $101.67 | $11.25 |
| Revenue Next Year | $10.87 | $7.76 |
| P/E Ratio | ★ N/A | $8.42 |
| Revenue Growth | ★ 78.61 | 16.49 |
| 52 Week Low | $1.25 | $23.89 |
| 52 Week High | $5.92 | $53.69 |
| Indicator | STIM | NCSM |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 38.37 |
| Support Level | $1.34 | $39.00 |
| Resistance Level | $1.50 | $40.69 |
| Average True Range (ATR) | 0.16 | 1.45 |
| MACD | 0.09 | -0.43 |
| Stochastic Oscillator | 94.80 | 26.65 |
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.